These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 37306912)

  • 1. Cancer Chemoresistance; Recent Challenges and Future Considerations.
    Adil M; Kanwal S; Rasheed S; Iqbal M; Abbas G
    Cancer Treat Res; 2023; 185():237-253. PubMed ID: 37306912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microenvironment acidity as a major determinant of tumor chemoresistance: Proton pump inhibitors (PPIs) as a novel therapeutic approach.
    Taylor S; Spugnini EP; Assaraf YG; Azzarito T; Rauch C; Fais S
    Drug Resist Updat; 2015 Nov; 23():69-78. PubMed ID: 26341193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoresistance in cancer cells: exosomes as potential regulators of therapeutic tumor heterogeneity.
    Sharma A
    Nanomedicine (Lond); 2017 Sep; 12(17):2137-2148. PubMed ID: 28805111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into new mechanisms and models of cancer stem cell multidrug resistance.
    Garcia-Mayea Y; Mir C; Masson F; Paciucci R; LLeonart ME
    Semin Cancer Biol; 2020 Feb; 60():166-180. PubMed ID: 31369817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of resistance to chemotherapy in non-small cell lung cancer.
    Min HY; Lee HY
    Arch Pharm Res; 2021 Feb; 44(2):146-164. PubMed ID: 33608812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surmounting cancer drug resistance: New insights from the perspective of N
    Li B; Jiang J; Assaraf YG; Xiao H; Chen ZS; Huang C
    Drug Resist Updat; 2020 Dec; 53():100720. PubMed ID: 32892147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer chemoresistance and its mechanisms: Associated molecular factors and its regulatory role.
    Kannampuzha S; Gopalakrishnan AV
    Med Oncol; 2023 Aug; 40(9):264. PubMed ID: 37550533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Tumor Microenvironment in Chemoresistance: To Survive, Keep Your Enemies Closer.
    Senthebane DA; Rowe A; Thomford NE; Shipanga H; Munro D; Mazeedi MAMA; Almazyadi HAM; Kallmeyer K; Dandara C; Pepper MS; Parker MI; Dzobo K
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28754000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Emerging Roles of Exosomes in the Chemoresistance of Hepatocellular Carcinoma.
    Zhang J; Song Q; Wu M; Zheng W
    Curr Med Chem; 2021; 28(1):93-109. PubMed ID: 32000636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of drug catabolism, modulation of oncogenic signaling and tumor microenvironment in microbe-mediated pancreatic cancer chemoresistance.
    Capula M; Perán M; Xu G; Donati V; Yee D; Gregori A; Assaraf YG; Giovannetti E; Deng D
    Drug Resist Updat; 2022 Sep; 64():100864. PubMed ID: 36115181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance.
    Taddia L; D'Arca D; Ferrari S; Marraccini C; Severi L; Ponterini G; Assaraf YG; Marverti G; Costi MP
    Drug Resist Updat; 2015 Nov; 23():20-54. PubMed ID: 26690339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNAs (lncRNAs) signaling in cancer chemoresistance: From prediction to druggability.
    Eptaminitaki GC; Stellas D; Bonavida B; Baritaki S
    Drug Resist Updat; 2022 Dec; 65():100866. PubMed ID: 36198236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Find new channel for overcoming chemoresistance in cancers: Role of stem cells-derived exosomal microRNAs.
    Hussein GM; Mohammed SM; Faris M; Mohammed A; Kadhim MJ; Awadh SA; Ajam WH; Jalil AT
    Int J Biol Macromol; 2022 Oct; 219():530-537. PubMed ID: 35948201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of MicroRNAs in the Chemoresistance of Breast Cancer.
    Wang J; Yang M; Li Y; Han B
    Drug Dev Res; 2015 Nov; 76(7):368-74. PubMed ID: 26310899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An emerging role of N-glycosylation in cancer chemoresistance.
    Sun Y; Wu T; Gu J
    Carbohydr Res; 2024 May; 539():109107. PubMed ID: 38613897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular Vesicles in Chemoresistance.
    De Rubis G; Bebawy M
    Subcell Biochem; 2021; 97():211-245. PubMed ID: 33779919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The multi-factorial nature of clinical multidrug resistance in cancer.
    Assaraf YG; Brozovic A; Gonçalves AC; Jurkovicova D; Linē A; Machuqueiro M; Saponara S; Sarmento-Ribeiro AB; Xavier CPR; Vasconcelos MH
    Drug Resist Updat; 2019 Sep; 46():100645. PubMed ID: 31585396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosomes and their roles in the chemoresistance of pancreatic cancer.
    Pan Y; Tang H; Li Q; Chen G; Li D
    Cancer Med; 2022 Dec; 11(24):4979-4988. PubMed ID: 35587712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of tumor microenvironment in cancer stem cell chemoresistance and recurrence.
    Das M; Law S
    Int J Biochem Cell Biol; 2018 Oct; 103():115-124. PubMed ID: 30153480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential role of miRNAs and exosomes in chemotherapy in ovarian cancer.
    Alharbi M; Zuñiga F; Elfeky O; Guanzon D; Lai A; Rice GE; Perrin L; Hooper J; Salomon C
    Endocr Relat Cancer; 2018 Dec; 25(12):R663-R685. PubMed ID: 30400025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.